ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

NERV Company Profile and Key Details

NASDAQ : NERV

Minerva Neurosciences, Inc.

$1.65

-0.03-1.79%

Open: 1:39 PM

61.82

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

NERV Stock Price Chart

Stock Price Today

Minerva Neurosciences, Inc. (NERV) stock declined over -1.79%, trading at $1.65 on NASDAQ, down from the previous close of $1.68. The stock opened at $1.67, fluctuating between $1.65 and $1.68 in the recent session.

Stock Snapshot

1.68

Prev. Close

1.67

Open

11.54M

Market Cap

6.99M

Number of Shares

1.65

Day Low

1.68

Day High

8.68

P/E Ratio

77.74%

Free Float in %

0.19

EPS (TTM)

-3.76

Book Value

-2.23

Cash Flow per Share

1.91K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 12, 2025	1.60	1.74	1.60	1.68	4.41K
Mar 11, 2025	1.60	1.66	1.54	1.55	2.34K
Mar 10, 2025	1.62	1.69	1.53	1.57	33.3K
Mar 07, 2025	1.71	1.77	1.60	1.64	20.49K
Mar 06, 2025	1.63	1.91	1.57	1.66	7.74K
Mar 05, 2025	1.58	1.80	1.53	1.66	18.86K
Mar 04, 2025	1.55	1.62	1.42	1.58	31.99K
Mar 03, 2025	1.73	1.74	1.53	1.53	89.62K
Feb 28, 2025	1.70	1.74	1.64	1.67	18.7K
Feb 27, 2025	1.76	1.78	1.69	1.70	10.7K
Feb 26, 2025	1.75	1.78	1.74	1.75	8.7K
Feb 25, 2025	1.80	1.86	1.71	1.79	30.74K
Feb 24, 2025	1.84	1.97	1.78	1.79	15.64K
Feb 21, 2025	1.84	1.91	1.81	1.82	27.7K
Feb 20, 2025	1.86	1.93	1.77	1.84	15.4K
Feb 19, 2025	1.92	2.05	1.80	1.85	194.46K
Feb 18, 2025	1.95	1.99	1.91	1.95	23.02K
Feb 14, 2025	2.04	2.04	1.91	1.97	43.42K
Feb 13, 2025	2.03	2.20	1.99	2.05	17.14K
Feb 12, 2025	2.00	2.01	1.92	1.96	69.61K

Contact Details

Waltham, MA 02451

United States

Website: https://www.minervaneurosciences.comContact: 617 600 7373

About Company

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Frequently Asked Questions

What is the current Minerva Neurosciences, Inc. (NERV) stock price?

Minerva Neurosciences, Inc. (NASDAQ: NERV) stock price is $1.65 in the last trading session. During the trading session, NERV stock reached the peak price of $1.68 while $1.65 was the lowest point it dropped to. The percentage change in NERV stock occurred in the recent session was -1.79% while the dollar amount for the price change in NERV stock was -$0.03.

NERV's industry and sector of operation?

The NASDAQ listed NERV is part of Biotechnology industry that operates in the broader Healthcare sector. Minerva Neurosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NERV?

Dr. Remy Luthringer Ph.D.
Executive Chairman & Chief Executive Officer
Mr. Geoffrey Robin Race F.C.M.A., FCMA, M.B.A., MBA
Pres
Mr. Frederick W. Ahlholm CPA, CPA
Senior Vice President, Chief Financial Officer & Sec.
Mr. Joseph Reilly
Senior Vice President & Chief Operating Officer
Mr. William B. Boni
Vice President of Investor Relations & Corporation Communications
Prof. Michael Davidson M.D.
Chief Medical Officer
Dr. Ramana Kuchibhatla Ph.D.
Senior Vice President and Head of R&D

How NERV did perform over past 52-week?

NERV's closing price is 18.31% higher than its 52-week low of $1.42 where as its distance from 52-week high of $3.69 is -54.47%.

How many employees does NERV have?

Number of NERV employees currently stands at 8.

Link for NERV official website?

Official Website of NERV is: https://www.minervaneurosciences.com

How do I contact NERV?

NERV could be contacted at phone 617 600 7373 and can also be accessed through its website. NERV operates from 1601 Trapelo Road, Waltham, MA 02451, United States.

How many shares of NERV are traded daily?

NERV stock volume for the day was 1.91K shares. The average number of NERV shares traded daily for last 3 months was 46.51K.

What is the market cap of NERV currently?

The market value of NERV currently stands at $11.54M with its latest stock price at $1.65 and 6.99M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	8
Beta	0.09
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology